https://www.pharmacypracticenews.com 2026-04-09 daily 1.0 https://www.pharmacypracticenews.com/Section/Multimedia/550 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Clinical/50 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Online-First/239 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Policy/51 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Operations-and-Management/53 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Pharmacy-Technology-Report/52 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Industry-News/599 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Review-Articles/63 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/FDA-News/585 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Monographs-and-Whitepapers/591 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Opinion/451 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Covid-19/666 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/People-in-Pharmacy/446 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Section/Compliance/711 2026-04-09 weekly 0.8 https://www.pharmacypracticenews.com/Category/Oncology/12 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Medication-Safety/10 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Infectious-Diseases/9 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Immunology/8 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Biosimilars/2 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Neurology/41 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Nutrition/11 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Pain/34 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Inflammatory-Diseases/35 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Pulmonology/33 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Cardiology/5 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Pharmacogenomics/32 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Endocrinology/29 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Critical-Care/6 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/GI-Disorders/7 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Women’s-Health/14 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Hematology/4 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Category/Vaccination/13 2026-04-09 weekly 0.7 https://www.pharmacypracticenews.com/Multimedia/Oncology/Article/04-26/Best-Practices-Clinical-Trials-Across-the-Enterprise/80247 2026-04-07 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Oncology/Article/04-26/National-Oncology-Pharmacists-Day/80195 2026-04-02 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Liver-Supplements-Market-Growth-Despite-Limited-Evidence/80124 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/04-26/Oncology-Pharmacist-Day-Elevates-Profession-Profile/80197 2026-04-02 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/03-26/Hazardous-Drug-AI-Future-Safe-Handling/79972 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-26/Oral-Chemotherapy-Benefits-With-Pharmacist-Managed-Care/79971 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/04-26/Antibiotic-Stewardship-Grand-Rounds-Benefit-Rehab-Patients/80165 2026-04-01 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/04-26/Intravenous-Immunoglobulin-Therapy-Dermatomyositis-Safety/80190 2026-04-07 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-26/Hospital-Accreditation-Overhaul-Joint-Commission-Accreditation360/79973 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Oncology/Article/03-26/HOPA-340B-Drug-Pricing-Program-Updates/80166 2026-03-31 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Liver-Screening-Feasibility-In-General-Population/80127 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-26/Industrial-Hygiene-Clues-for-Safer-Hazardous-Drug-Monitoring/79975 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/03-26/Biosimilar-Uptake-Surge-After-Order-Set-Change-Academic-Center/80154 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-26/CAR-T-Hematotoxicity-Scoring-Tools-Synergy/80150 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-26/Clinical-Safety-Nonsterile-Hazardous-Compounding-Practices/79976 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Pharmacy-Neurology-Medication-Safety-Huntington-s-Disease/80149 2026-03-30 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Clinical-Manufacturers-Decisions-Patient-Assistance-Programs/80123 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Patient-Access-Policy-Financial-Pressures-2026/80122 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/MASLD-Awareness-Gaps-in-Care-and-Referrals/80126 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Patient-Access-Challenges-Keeping-Teams-Awake/80121 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/BRAF-Inhibitors-Transforming-Pediatric-Oncology-Pharmacy/80118 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Gastric-Cancer-Esophageal-Treatment-Evolution/80115 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/GLP1-oncology-evidence-and-shared-decision-making/80104 2026-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/03-26/Malone-quits-ACIP-confusion-vaccine-recommendations-RFK-Jr/80111 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Oncology/Article/03-26/HOPA-Oncology-Pharmacy-GLP-1s-Weight-Loss-Cancer-Treatment/80110 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Oncology-Theranostics-in-Pharmacy-Practice/80103 2026-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/bloodstream-infection-heart-attack-outcomes-Critical-Care-Congress-2026/80101 2026-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Medicaid-Cuts-Threaten-340B-Eligibility-SafetyNet-Hospitals/80095 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/03-26/Oncology-Pharmacy-Residency-Leadership-Gaps-Survey/80094 2026-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Oncology/Article/03-26/Oncology-Pharmacy-Gastric-Esophageal-Cancers-Treatment/80092 2026-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/CNS-Metastasis-Pharmacists-Driving-Advanced-Care/80091 2026-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/cefepime-antibiotics-induced-neurotoxicity-Critical-Care-Congress-2026/80089 2026-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/Actinomyces-infections-appropriate-antibiotics-Critical-Care-Congress-2026/80088 2026-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/IV-push-beta-lactam-antibiotics-infusion-style-Critical-Care-Congress-2026/80084 2026-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/daptomycin-dosing-antibiotics-Critical-Care-Congress-SCCM-2026/80079 2026-03-24 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-26/IDNs-Critical-Access-Gene-Therapies/79866 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Tardive-Dyskinesia-Pharmacy-Medication-Safety-Neurology/80073 2026-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/antibiotic-therapy-course-length-hospital-acquired-pneumonia/80071 2026-03-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/rapid-diagnosis-detecting-anaerobic-gram-negative-bacteria-bloodstream-infections-Critical-Care-Congress-2026/80070 2026-03-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/rapid-diagnostic-sepsis-ER-IntelliSep-Critical-Care-Congress-2026/80069 2026-03-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/IV-or-oral-antibiotics-for-Pyelonephritis-kidney-infection-Critical-Care-Congress-2026/80063 2026-03-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/03-26/new-Surviving-Sepsis-guidelines-adult-children-Critical-Care-Congress-SCCM-2026/80061 2026-03-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Pediatric-Parenteral-Nutrition-Home-Safety-Challenges/79865 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Patient-Assistance-and-Specialty-Pharmacy-Collaboration/80055 2026-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/03-26/Tardive-Dyskinesia-Burden-Perspectives-from-Physicians-and-Patients/80040 2026-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Tardive-Dyskinesia-in-Children-and-Adolescents-Uncommon-but-Not-Absent/80038 2026-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/03-26/Rare-Disease-Speciality-Pharmacy-Program/79863 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/03-26/IV-Compounding-Innovation-Integration-Transformation/79974 2026-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Huntington-s-Disease-Neurology-Pharmacy/80017 2026-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Implicit-Bias-in-Specialty-Pharmacy-Care/79860 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/IBD-Pharmacists-Keys-to-Better-Patient-Care/79859 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Infectious-Diseases/Article/03-26/federal-judge-strikes-down-ACIP-vaccine-changes-CDC/80012 2026-03-17 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Biosimilar-Reimbursement-Policies-Impact-on-Sustainability/79858 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Pharmacy-Tardive-Dyskinesia-Neurology/80001 2026-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-26/Cold-Chain-Packaging-Fees-for-Missing-Green-Targets/79857 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Pharmacy-Medication-Huntington-s-Disease/79996 2026-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-26/Pharmacy-Concerns-Over-Amazon-Medication-Kiosks/79856 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Tardive-Dyskinesia-Seen-but-Unseen-in-Long-Term-Care/79991 2026-03-12 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/03-26/Tardive-Dyskinesia-Polypharmacy-Challenge/79989 2026-03-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-26/Breast-Cancer-Targeted-Therapy-Oral-Options/79977 2026-03-12 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-26/Compounding-IV-Workflow-Pestle-Formulas-System-Launch/79988 2026-03-12 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-26/Alternative-Funding-Plan-Risks-for-Patient-Care/79855 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-26/Antibiotic-Dalbavancin-Injection-Generic-Launch-Long-Grove/79987 2026-03-12 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-26/Pharmacy-benefit-management-relationship-tips/79854 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Higher-Cost-Specialty-Therapies-Moving-Up/79853 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Biosimilar-Use-Uptake-Inflammatory-Conditions-Gap/79852 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-26/Diabetes-Telehealth-Med-Management-Program-Slashes-A1c/79918 2026-03-09 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Remdesivir-Criteria-Save-Costs-Preserve-Clinical-Outcomes/79851 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Pharmacist-Led-IBD-Research-Care/79864 2026-03-09 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-26/Reimbursement-Barriers-Coverage-Gaps-for-Digital-Therapeutics/79895 2026-03-06 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-26/Buprenorphine-safer-choice-managing-cancer-pain-access-issues/79850 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-26/Resources-for-Payment-Changes/79890 2026-03-05 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-26/Immunoglobulin-Financial-Support-for-Ig-Patients/79849 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-26/Adherence-Support-Boosts-Specialty-Pharmacy-Outcomes/79882 2026-03-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Pharmacy-Neurology-Huntington-s-Disease/79876 2026-03-13 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Nutrition/Article/03-26/Parenteral-Nutrition-Therapy-Assessment-Tools-Guidelines/79845 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-26/Clinical-Rare-Disease-Drug-Approvals-Survey-Care-Gaps/79839 2026-03-02 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/04-26/Prescription-Drugs-TrumpRx-Highlight-in-SOTU-Address/79835 2026-04-01 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/03-26/Pharmacy-Tardive-Dyskinesia/79834 2026-03-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Tardive-Dyskinesia-Masking-and-Unmasking/79816 2026-02-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Dental-Complications-Tardive-Dyskinesia-Care-Insights/79814 2026-02-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-26/PBM-Reform-Legislation-Praised-But-Needs-Expansion/79812 2026-02-25 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Neurology/Article/02-26/Pharmacy-Neurology-Tardive-Dyskinesia/79808 2026-02-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Tardive-Dyskinesia-Center-of-Excellence-Model/79803 2026-02-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/02-26/Immunoglobulin-Therapy-In-Solid-Organ-Transplantation/79768 2026-02-24 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/02-26/RFID-Pharmacy-Innovation-Beyond-Kits-and-Trays/79729 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-26/USP-797-Compliance-Gap-and-Three-Ps-Approach/79726 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/02-26/Live-Therapeutics-Handling-Without-Guiding-Document/79723 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-26/Cleanroom-Downtime-Management-and-Surface-Sampling/79725 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Tardive-Dyskinesia-Pharmacists-Help-Close-Diagnosis-Gap/79722 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-26/Drug-Shortages-ASHP-Report-2025-Decline/79741 2026-02-19 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/02-26/Biosimilar-Uptake-Uneven-Across-Drug-Classes/79724 2026-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-26/Rural-Healthcare-Drug-Pricing-2026-Challenges-Opportunities/79728 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/02-26/Pediatric-HPN-Discharge-Model-Reduces-Infections-Readmissions/79736 2026-02-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Huntington-Disease-Early-Treatment-Priorities-Reframed/79714 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Huntington-Gene-Therapy-Expectations-Management/79718 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-26/340B-Rebate-Model-Withdrawal-Debate-Continues/79716 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Neurology/Article/02-26/Tardive-Dyskinesia-Daily-Burden-Still-Misunderstood/79712 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/02-26/GLP-2-Era-Redefines-the-Art-of-Intestinal-Rehabilitation-Say-Experts-at-ASPEN/79710 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/02-26/GLP1-Pediatric-Obesity-Care-Expands-With-Caution/79709 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/02-26/Pharmacy-Automation-Cuts-Processing-Time/79700 2026-02-13 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/02-26/Event-Reporting-Pharmacy-System-Medication-Medical-Errors/79682 2026-02-12 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/02-26/Ovarian-Carcinoma-Keytruda-Paclitaxel-FDA-Approval/79666 2026-02-12 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-26/Drug-Diversion-Team-WVU-Proactive-Planning-Success/79660 2026-02-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-26/Medication-TrumpRx-Consumer-Website-Launch/79656 2026-02-11 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/02-26/Tardive-Dyskinesia-Distinguishing-From-Drug-Induced-Disorders/79588 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/02-26/ASHP-Pharmacy-Event-Reporting-Medication-Safety/79615 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-26/Healthcare-Tourism-Global-Patient-Safety-Insights/79589 2026-02-04 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/02-26/Medication-Safety-Errors-Year-in-Review/79587 2026-02-11 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/02-26/Tardive-Dyskinesia-Why-Mild-Cases-Are-Hardest-To-Manage/79583 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/02-26/Tardive-Dyskinesia-Management-Gaps-in-LongTerm-Care/79581 2026-02-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/02-26/Medical-Cannabis-Program-New-York-Opioid-Reduction/79565 2026-02-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/02-26/Drug-Diversion-Software-Trust-Workflow-Follow-Through/79577 2026-02-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/02-26/Medical-Supply-Chain-Resilience-Affects-Patient-Care/79564 2026-02-04 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/01-26/Tdap-Education-Boosts-Pharmacist-Stewardship-in-ED/79450 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/01-26/Multiple-Myeloma-FDA-Approval-Darzalex-Faspro-VRd/79549 2026-01-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/01-26/Rabies-Prevention-Facts-and-Myths/79451 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Burnout-Types-and-Tips-for-Recovery/79452 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/01-26/CAR-T-Therapy-Readiness-in-Health-Systems/79453 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/01-26/Immune-Homeostasis-Restoration-In-Long-COVID/79454 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Assessing-Tardive-Dyskinesia-AIMS-and-the-Clinicians-Tardive-Inventory/79522 2026-01-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Inflammatory-Diseases/Article/01-26/Specialty-Pharmacists-Improve-Inflammatory-Disease/79512 2026-01-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/VMAT2-Inhibitors-Huntington-Disease-Chorea-Management/79516 2026-01-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-26/Pharmacist-Driven-HCV-Management-Success/79511 2026-01-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-26/Tardive-Dyskinesia-AI-Video-Detection-Diagnosis-Gap/79510 2026-01-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Tardive-Dyskinesia-VMAT2-Inhibitors-Reshaping-Care/79508 2026-01-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/Payment-Changes-2026-Opportunities-in-Healthcare/79455 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Medication-Safety-ADC-Insights-From-ASHP-Midyear/79456 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/01-26/Remdesivir-Criteria-Save-500K-Without-Affecting-Outcomes/79449 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/01-26/MRSA-Screening-PCR-Stewardship-Success/79448 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/RhIG-Oversight-Quality-Improved-by-Pharmacist-Leadership/79447 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Specialty-Pharmacy-Automation-Time-Savings/79459 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/02-26/Aging-HIV-Pharmacy-Medication-Infectious-Diseases/79506 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/VMAT2-Inhibitor-Tardive-Dyskinesia-Treatment-Complexity/79502 2026-01-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Psychiatric-Impact-and-Cognitive-Toll-in-Huntington-Disease/79501 2026-01-23 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/01-26/Nursing-Contractors-Vetting-for-Safe-Home-Infusions/79500 2026-01-23 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Inflammatory-Diseases/Article/01-26/Ocrelizumab-Subcutaneous-Formulation-Preferred/79498 2026-01-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pulmonology/Article/01-26/COPD-Treatments-Breathe-New-Life-Into-Chronic-Disease/79446 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Pharmacists-Refill-Management-Leadership-University-Hospitals/79445 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Pulmonary-Hypertension-Successful-Management-Model/79490 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/Visual-Inspection-in-Sterile-Compounding-Cleanroom/79443 2026-01-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Clinical-Pharmacists-Becoming-Exceptional-Healthcare-Leaders/79442 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-26/HIV-Pharmacists-Support-Patients-Transitioning-to-LA-ART/79477 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Pharmacy-Access-NCPA-Closure-Mapping-Tool/79471 2026-01-21 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Tardive-Dyskinesia-Diagnosis-Critical-for-Optimal-Outcomes/79465 2026-01-20 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Artificial-Intelligence-Boosts-Prior-Authorization-Efficiency/79458 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Controlled-Substance-Diversion-Surveillance-in-Hospitals/79457 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/Clinical-340B-Rebate-Plan-Reprieve-Leaves-CEs-Uncertain/79444 2026-01-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/Rabies-Transmission-Linked-To-Organ-Transplant/79423 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Drug-Manufacturer-Provider-Partners/79438 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Gene-Therapy-Market-Complexity/79437 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/Pharmacy-Benefit-Managers-Challenges/79436 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-26/Pharmacy-Collaboration-Improves-Medicaid-Adherence/79435 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/01-26/ASHP-Pharmacy-Federal-State-Policy/79434 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/01-26/Specialty-Pharmacy-Technology-Advancements/79433 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Cell-Therapy-Promise-to-Practice-Access/79432 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Home-Infusion-Providers-Strategies-Against-Payors-PBMs/79431 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Hepatitis-C-Pharmacists-Achieve-97-Cure-Rate/79430 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/Specialty-Prescriptions-Unfilled-IQVIA-Data-Findings/79429 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-26/340B-Drug-Pricing-Discounts-at-Risk-2025/79428 2026-01-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Compliance-Tips-Avoiding-Legal-Trouble-With-PBMs-Regulators/79427 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Pharmacists-Can-Drive-Improved-Tardive-Dyskinesia-Screening-and-Care-Real-World-Data-Suggest/79370 2026-01-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Tardive-Dyskinesia-Cases-Undiagnosed-Real-World-Study/79369 2026-01-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Gene-Therapy-FDA-Review-Slows-Huntington-Progression/79368 2026-01-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Tardive-Dyskinesia-Management-Risks-and-Therapeutic-Advances/79341 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/FDA-Grants-First-Priority-Voucher-Approval/79344 2026-01-09 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/Osteomyelitis-Aspergillus-Rare-Treatable-fungal-infection/79337 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/pertussis-whopping-cough-rates-rising/79336 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/flu-deaths-rising-influenza-update/79334 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/Antimicrobial-efficacy/79330 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/01-26/childhood-vaccine-rollback-US-children-risk/79329 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/01-26/Pharmacy-Medication-Patient-Safety-Event-Investigation/79325 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/01-26/CDC-drops-childhood-shots-recommendations/79316 2026-01-07 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-25/FDA-Rubraca-Approval/79286 2025-12-31 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-25/FDA-Rybrevant-Faspro-Approval/79285 2025-12-31 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/340B-Pilot-Financial-Risks-for-Covered-Entities/79277 2025-12-31 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Oncology/Article/01-26/Breast-Cancer-Primer-New-Treatments-Supportive-Care/78977 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/12-25/Medication-Errors-Review-and-Prevention-Strategies/78976 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Infectious-Diseases/Article/12-25/Rabies-prevention-facts-and-fantasies/78975 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Infectious-Diseases/Article/12-25/Urinary-Tract-Infections-Antimicrobial-Resistance-Updates/78974 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Cardiology/Article/12-25/PSVT-treatment-FDA-approval-Cardamyst-spray/79247 2025-12-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-26/Oncology-Precision-Expands-Oral-Options-Breast-Cancer/79188 2026-03-03 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-25/Hepatitis-B-CDC-adopts-ACIP-recommendation-changes/79242 2025-12-18 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/12-25/Best-Practices-DEA-Drug-Enforcement-Administration-Audit-Pharmacy-Medication-Hospitals-Pharmacists/79240 2025-12-17 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Nutrition/Article/12-25/Parenteral-Nutrition-Order-Review-Skills-Competencies/78973 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/12-25/Pharmacy-AI-Artificial-Intelligence-Data/79216 2025-12-16 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Oncology/Article/01-26/Lung-Cancer-Novel-Agents-in-Metastatic-NSCLC/78972 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-25/FDA-approves-blujepa-gepotidacin-gonnorhea-STIs/79212 2025-12-15 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/01-26/Gene-Therapy-Pharmacists-Guiding-Patients-Life-Changing-Journeys/79186 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Infectious-Diseases/Article/12-25/Antimicrobial-Efficacy-Review-Guide/78971 2025-12-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/01-26/Biosimilar-Patient-Experience-Focus-NASP-2025/79185 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Medication-Assistance-Why-Patients-Delay-Services/79184 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/01-26/Immunodeficiency-Secondary-A-nbsp-Growing-Healthcare-Concern/78989 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-25/Oral-Nuzolvence-Approved-for-Gonorrhea/79200 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/12-25/Cefiderocol-Use-Evaluation-Fetroja-Appropriateness/78987 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/12-25/CMV-Prophylaxis-Prevymis-Effectiveness-After-Kidney-Transplant/78986 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/12-25/Remdesivir-Lower-In-Hospital-Mortality-COVID19-Liver-Kidney-Disease/78985 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/12-25/Biosimilars-Relief-in-Sight-for-Interchangeable-Access/78984 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/01-26/Immunotherapy-Bispecific-Antibodies-Dual-Threat-Tumors/78979 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-25/Prior-Authorization-Payment-Preparation-Strategies/78983 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-25/340B-Reform-Transparency-Oversight-Accountability/78982 2025-12-12 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-25/PCR-MRSA-Nasal-Screening-Study-ASHP-Midyear/79179 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-25/cabenuva-real-world-HIV-treatment-ASHP-Midyear/79178 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-25/tdap-vaccine-registry-stewardship-ASHP/79175 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-25/C-diff-fidaxomicin-antibiotic-ASHP-Midyear/79174 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/12-25/Infusion-Standardization-Reducing-Smart-Pump-Errors/79176 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-25/remdesivir-covid-19-cost-savings-ASHP-Midyear/79173 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/AI-Streamlining-Clinical-Trials/79150 2025-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/12-25/Pharmacy-Medication-Medicine-Safety-Compliance/79128 2025-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/CMS-Medicare-Drug-Negotiations/79126 2025-12-09 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/Pharmacist-Led-DVT-Clinic-Success/79125 2025-12-09 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/12-25/Medication-Safety-Best-Practices/79121 2025-12-09 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/Sterile-Compounding-Visual-Inspection/79004 2025-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-25/Hospital-Pharmacy-Compounding-Challenges/78980 2025-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pulmonology/Article/12-25/COPD-New-Treatment-Options/78993 2025-12-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Immunology/Article/01-26/RhIG-Pharmacy-Oversight-Benefits/79003 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/340B-Program-Shelbyville-Hospital/78988 2025-12-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/Outpatient-Pharmacists-Medication-Refill-Management/79073 2025-12-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/12-25/ACIP-End-HepB-Birth-Dose/79080 2025-12-11 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-25/Tarlatamab-DLLE-Approval-Lung-Cancer/79022 2025-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-25/HBV-Hepatitis-Delta-Screening-Guidelines/79021 2025-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-25/Generic-Biosimilars-Healthcare-Savings/78969 2025-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/12-25/Wrong-Route-Errors-Spur-New-TXA-Alert-From-Safety-Experts/78981 2025-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-25/Political-Mischief-Influencing-ACIP/79012 2025-12-03 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-25/Sevabertinib-Approval-Nonsquamous-NSCLC-Treatment/79006 2025-12-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/12-25/Purdue-Pharma-Settlement-Impact/78997 2025-12-02 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/12-25/Pharmacy-Behavioral-Health/78990 2025-12-01 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-25/DSCSA-Compliance-Pharmacy-Challenges/78945 2025-11-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-26/Pharmacists-Climate-Change-Preparedness/78879 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Specialty-Pharmacy-Performance-Measures/78892 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/01-26/Specialty-Pharmacies-Innovation-Challenges/78894 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/01-26/FDA-Approved-Cancer-Drugs/78883 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Inflammatory-Diseases/Article/01-26/Treating-Pediatric-Inflammatory-Bowel-Disease/78885 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/01-26/BsAbs-Cancer-Treatment-Toxicities/78884 2026-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-25/Antimicrobial-Resistance-Challenges-Solutions/78889 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/12-25/Recombinant-Human-Hyaluronidase-PH20-in-Biologics-and-Immunoglobulin-Therapy/78886 2025-12-02 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-25/Specialty-Pharmacy-Challenges-Agility/78881 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/11-25/Liver-Disease-Malnutrition-Treatment-Options/78882 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-25/Reimbursement-Matters-Health-System/78891 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-25/Antibiotic-Prophylaxis-Cirrhosis-Gastrointestinal-Bleeding/78890 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-25/Pharmacy-Compliance-NABP-Inspections/78880 2025-11-19 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-25/Rare-Diseases-Infrastructure-Innovation/78893 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Immunology/Article/11-25/Home-Immunoglobulin-Therapy-Advantages/78854 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Immunology/Article/01-26/Ig-Therapy-Treatment-Options/78855 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/01-26/Immunoglobulin-Product-Indications-Differentiation/78860 2026-01-22 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-25/CAR-T-Therapy-Financial-Challenges/78903 2025-11-17 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/11-25/Immunologic-Anaphylactoid-Reactions-Ig-Therapy/78857 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/11-25/Pharmacist-Medication-Review-Safety/78888 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Pharmacogenomics/Article/11-25/Pharmacogenomics-Implementation-AI-Assistance/78896 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/11-25/Fibromyalgia-Treatment-Approval-Landmark/78887 2025-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Immunology/Article/11-25/Immunoglobulin-Therapy-Patient-Survey/78853 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/01-26/adstiladrin-bcg-unresponsive-non-muscle-invasive-bladder-cancer-nmibc-gene-therapy/78870 2026-01-20 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/11-25/Optimizing-Intravenous-Immunoglobulin-Therapy/78852 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/11-25/Certified-Competency-Ig-Therapy-Teams/78858 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/11-25/Immunoglobulin-Therapy-Aseptic-Meningitis-Syndrome/78856 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Immunology/Article/11-25/Subcutaneous-Immunoglobulin-Therapy-Fundamentals/78859 2025-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-25/VA-Medical-Center-Infection-Reduction/78847 2025-11-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-25/Veterans-Chronic-Respiratory-Conditions/78846 2025-11-07 monthly 0.6 https://www.pharmacypracticenews.com/Opinion/Article/11-25/Legislative-and-Research-Efforts-to-Reduce-Opioid-Exposure-Progress-Challenges-and-Emerging-Threats/78814 2025-11-06 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-25/TrumpRx-Pfizer-Drug-Pricing/78812 2025-11-05 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/11-25/FDA-Approves-Fosfomycin-Injection-UTI-Contepo/78794 2025-11-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-25/Pharmacy-Compliance-Inspection-Findings/78766 2025-11-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-25/Cleanroom-Compliance-Excursions-A-Primer/78012 2025-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/AFPs-Affect-Access-to-Specialty-Medications/78769 2025-10-31 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Appropriate-Use-Cefiderocol-Antibiotic-Resistance/78754 2025-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Dalbavancin-Treatment-Veterans-Infections/78737 2025-10-27 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/10-25/Tranexamic-Acid-FDA-Warning/78735 2025-10-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/10-25/AI-Efficiency-and-Patient-Safety/78595 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Pharmacists-Social-Media-Best-Practices/78596 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Compass-Rose-Software-Success/78597 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-25/Belantamab-Mafodotin-Multiple-Myeloma-Treatment/78723 2025-10-24 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/AI-Easing-Pharmacy-Prior-Authorization/78598 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/LDD-Networks-Specialty-Pharmacy/78588 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/340B-Program-Oversight-Reform/78720 2025-10-23 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Index-for-DTR-Resistance-May-Help-Gauge-Antibiotics-Effectiveness/78717 2025-10-23 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Premyvis-Kidney-Transplant/78716 2025-10-23 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/10-25/Remdesivir-Treatment-Lowering-COVID-Mortality/78715 2025-10-23 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Sterile-Compounding-Disinfectant-Best-Practices/78586 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/340B-Federal-Drug-Pricing-Campaign/78591 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Cleanroom-Disinfection-Procedures-Update/78585 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Microbiological-Air-Surface-Monitoring/78583 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/10-25/HIVMA-HIV-Research-IDWeek-2025-Anna-Person/78692 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/Pharmacist-Moral-Dilemmas-Advocacy-Ethics/78593 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/IV-Saline-Shortage-Ended/78590 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/White-Bagging-Challenges-Survey/78594 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/11-25/Fosun-Pharma-MAP-International-Collaborate-to-Deliver-Pain-Relief-Medication/78703 2025-11-10 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Biosimilars/Article/10-25/Yuflyma-Expanded-Indications-Adolescent-Hidradenitis-Suppurativa/78701 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-25/MPOX-Vaccination-HIV-Study/78694 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-25/CDI-Mortality-Rates-Study/78695 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Johns-Hopkins-Hospital-Dashboard-Tracking/78584 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/10-25/RSV-Nirsevimab-Abrysvo-Pregnancy-Baby/78693 2025-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Making-Surface-Air-Sampling-Data-Work-for-You/78582 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Cleanroom-Certification-Excursion-Remediation/78581 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-25/Pharmacy-Leaders-Combat-Vaccine-Misinformation/78599 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Adverse-Events-Mitigation-Ig-Therapy/78682 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Pharmacist-Advocacy-COVID-19-Vaccinations/78600 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/10-25/Medication-Safety-System-Vulnerabilities/78589 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/At-IgNS-Conference-a-Focus-on-New-Complement-Inhibitors/78673 2025-10-20 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Pharmacogenomics/Article/10-25/Pharmacogenomics-Implementation-Hospitals/78657 2025-10-16 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Lurie-Childrens-Specialty-Pharmacy-Chicago/78587 2025-10-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Malnutrition-Threat-Hospital-Safety/78580 2025-10-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Pharmacy-Vaccine-Policy-Response/78579 2025-10-17 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Hospital-Pharmacy-Compounding-Challenges/78578 2025-10-17 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/10-25/Affordability-Access-Speciality-Pharmacy-Pharmacists/78627 2025-10-14 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Medicare-Drug-Price-Negotiation/78654 2025-10-16 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/10-25/Pharmacists-Pharmacy-Patients-Health-related-Social-Needs-Social-Determinants-Health-Race-Gender-Income-Geography/78626 2025-10-14 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/Optimizing-Payment-Depends-on-Data-and-Revenue-Integrity/78592 2025-10-15 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/10-25/NASP-ASIP-COVID-Vaccine/78617 2025-10-14 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/10-25/Medication-Safety-Dashboards-Insights/78224 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Minnesota-Health-Plans-Collaboration/78460 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Patient-Assistance-Program-Solutions/78225 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-25/Home-Immunoglobulin-Therapy-Benefits/78459 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Digital-Medicine-Program-Success/78226 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/MVA-vaccine-mpox-prevention/78522 2025-10-09 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-25/GLP-1-Receptor-Agonist-Coverage-Decline/78458 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/3D-Printing-Compounded-Medications-SEO/78227 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Minority-Children-Food-Allergies/78457 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/CGM-User-and-Technical-Errors/78228 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/AI-Managed-Care-Pharmacy/78230 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-25/Food-Environment-MASLD-Mortality-Study/78456 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-25/Lurbinectedin-Atezolizumab-ES-SCLC-Treatment/78468 2025-10-06 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Can-Epics-Dispense-Prep-Cover-Your-IV-Workflow-Needs/78229 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/10-25/Good-Catch-Reports-Improvement/78231 2025-10-03 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-25/Specialty-Therapies-Cost-Reduction/78232 2025-10-23 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-25/Inluriyo-FDA-Approval-Breast-Cancer/78447 2025-10-02 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Microbiological-Air-Surface-Monitoring/78011 2025-09-30 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Immediate-Use-Compounding-Pain-Points/78413 2025-09-30 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Health-System-Specialty-Pharmacists/78433 2025-10-01 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Trump-Truth-Social-Tariff-Announcement/78429 2025-10-01 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-25/Specialty-Pharmacy-Medication-Definition/78426 2025-10-01 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Medicare-Physician-Fee-Schedule/78270 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Pharmacy-Residency-Accreditation-Success/78271 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/09-25/Vaccines-Promising-for-Pancreatic-Cancer/78269 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/09-25/CROI-2025-HIV-Treatment-Advances/78268 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/09-25/Oncology-Medication-Prior-Authorization/78267 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/09-25/Medication-Safety-Best-Practices/78265 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/09-25/Advanced-Therapeutics-Access-Affordability-Solutions/78264 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Medicare-Hospital-Payment-Rules/78263 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/09-25/Med-Safety-Experts-Urge-Using-Range-Of-High-and-Low-Impact-Interventions/78262 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/09-25/IV-Smart-Infusion-Pumps/78273 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Medicare-Hospitals-Accreditation-Scrutiny-Survival/78261 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/State-Level-Progress-Made-on-Key-Pharmacy-Issues/78272 2025-09-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/09-25/FDA-Removes-CAR-T-REMS/78266 2025-09-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Pharmacist-Blackburn-CDC-Role/78335 2025-09-22 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/09-25/ACIP-COVID-19-Vaccine-Prescription/78333 2025-09-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/ACIP-Tables-HepB-Birth-Dose-Vote/78328 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Specialty-Pharmacists-PAH-Management-Improvement/78323 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/ACIP-Meeting-MMRV-Vaccine-Withdrawal/78321 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Insurers-Promise-to-Cover-Vaccines/78314 2025-09-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Specialty-Pharmacy-LDD-Networks/78310 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Medication-Safety-Community-Pharmacy/78309 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/NASP-Survey-Spotlights-Challenges-of-White-Bagging/78308 2025-09-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/State-Pharmacy-Vaccine-Policies/78304 2025-09-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/FDA-Green-List-GLP-1-Alert/78289 2025-09-16 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/US-Antibiotics-Working-with-Walmart-McKesson-to-Address-ABX-Shortage/78282 2025-09-16 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/California-SSPE-Measles-Death/78281 2025-09-16 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Pertussis-Record-High-Louisiana/78280 2025-09-16 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-25/AI-Pharmacy-Administration-Advancements/78274 2025-09-15 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Nutrition/Article/02-26/Nutrition-Support-Pharmacists-Pharmacy-Education-Decline/78256 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/HHS-Health-Insurance-Rule/78253 2025-09-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/09-25/Malnutrition-Threat-Hospitals-SEO/78244 2025-09-12 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-25/Koselugo-Approved-Pediatric-Neurofibromatosis-Treatment/78222 2025-09-11 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/09-25/Inlexzo-Approval/78219 2025-09-11 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/HHS-MAHA-Strategy-Document-Targets-Vaccines/78217 2025-09-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/Pharmacists-Combat-Vaccine-Misinformation/78200 2025-09-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Cardiology/Article/09-25/Camzyos-Specialty-Pharmacy-Management/78170 2025-09-09 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Endocrinology/Article/09-25/AI-Pharmacy-Navigation-Platform/78155 2025-09-05 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/More-States-Establish-Their-Own-Vaccine-Policies-as-RFK-Jr-Continues-Anti-Vaccine-Push/78121 2025-09-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/09-25/Senators-Grill-RFK-Jr-on-Vaccines-as-Health-Organizations-Demand-His-Ouster/78122 2025-09-04 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/09-25/state-vaccine-recommendations-outside-ACIP/78087 2025-09-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/09-25/IV-Saline-Shortage-Ends/78083 2025-09-04 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/09-25/Parenteral-Nutrition-Guidelines-for-Pediatric-and-Neonatal-Patients/78077 2025-09-02 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/09-25/CVS-stops-COVID-shots/78073 2025-09-02 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/CDC-Leadership-Loss/78063 2025-08-29 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/FDA-Rescinds-EUA-but-Approves-Updated-2025-2026-COVID-Vaccines/78057 2025-08-27 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/08-25/Ketogenic-Diet-Mental-Health/77905 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/08-25/Elimination-Diets-GI-Diseases/77913 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/08-25/Camizestrant-AI-Switch-Breast-Cancer/77914 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/Reimbursement-Matters-Health-System/77911 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/Tech-Enabled-Pharmacy-Access-Models/77908 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/AI-Pharmacy-Practice-Continuum/77907 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/08-25/Perioperative-Medication-Management-Tips/77916 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/08-25/FDA-Approves-Papzimeos-for-Adults-With-Recurrent-Respiratory-Papillomatosis/78040 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/GI-Disorders/Article/08-25/Gut-Brain-Microbiome-Axis-Stress/77917 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/AI-Pharmacy-Human-Expertise/77906 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Infectious-Diseases/Article/08-25/Vaccine-Recommendations-Lawsuit-Threat/77909 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/08-25/Trauma-Informed-Approach-Pharmacists/77904 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/Pediatric-Compounding-Challenges-Solutions/77903 2025-08-22 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/08-25/Semaglutide-FDA-Approved-MASH-Treatment/78026 2025-08-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/HHS-and-Private-Health-Insurers-Team-Up-to-Improve-PAs/77912 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/09-25/Mood-Stabilizing-Drugs-Management/77918 2025-09-11 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/08-25/Crushed-Bictegravir-Emtricitabine-Tenofovir-Alafenamide-HIV/78008 2025-08-15 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/Public-Health-Report-RFK/78010 2025-08-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Endocrinology/Article/08-25/Pharmacist-Managed-Diabetes-Program-A1c-Levels/77985 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Endocrinology/Article/08-25/GLP-1s-Potential-New-Uses/77984 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/08-25/Drug-Safety-Community-Pharmacies/77983 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/HRSA-Lower-Drug-Prices/78020 2025-08-19 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Endocrinology/Article/08-25/GLP-1s-Pancreatic-Health-Benefits/77982 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/CMS-Proposed-Rule-Raises-Concerns/77999 2025-08-14 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/COVID-Cases-Increasing-Across-Most-of-the-Country/77987 2025-08-12 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/08-25/Hernexeos-Approval-Non-Small-Cell-Lung-Cancer/77980 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/08-25/Skincare-Products-Recalled-Because-of-B-cepacia-Contamination/77975 2025-08-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/U-S-Measles-Cases-Continue-to-Climb/77965 2025-08-08 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/09-25/ASHP-Best-Practices-Disinfectants-Sterile-Compounding-Areas-Pharmacy-Medication/77967 2025-09-30 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/Remdesivir-COVID-19-Patients-COPD/77966 2025-08-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/FDA-Updates-Opioid-Labeling-Requirements-to-Reflect-Long-Term-Risks/77799 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/CMS-Updates-COVID-19-Vaccination-Reporting-Requirements/77920 2025-08-07 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/08-25/SCIG-and-fSCIG-Therapy-Advancements/77915 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/340B-Winter-Coalition-Conference-Insights/77910 2025-08-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/RFK-Jr-Slashes-mRNA-Vaccine-Program-Funding/77919 2025-08-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/Low-Familiarity-With-Health-Plans-Financial-Assistance-Causes-People-to-Skip-or-Delay-Services-or-Medications/77887 2025-08-07 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/NCCN-Guidelines-Recommend-mAbs-for-COVID-19-PrEP-in-People-With-Cancer/77832 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/Specialty-Pharmacists-Help-Patients-Navigate-Risks-Associated-With-Anti-Inflammatory-Drugs/77806 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/Access-to-Oncology-Drugs-Stymied-by-Prior-Authorization-but-Specialty-Pharmacists-Can-Help/77804 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/02-26/lenacapavir-broadly-neutralizing-antibodies-HIV-treatment/77777 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Nutrition/Article/07-25/AI-Streamlining-TPN-Infant-Nutrition/77603 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/FDA-Imovax-Rabies-PrEP-expansion/77776 2025-07-29 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Generic-Methadone-Hydrochloride-Injection/77779 2025-07-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/07-25/Elderly-Healthcare-System-Survey/77599 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Safe-Home-PN-Often-Hinges-on-Checking-Prescriber-Accuracy/77594 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/4-Key-Categories-for-Managing-PN-Associated-Hyperglycemia/77593 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Anticoagulation-Safe-For-Older-Adults-With-Careful-Monitoring/77591 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/GI-Disorders/Article/08-25/FMT-May-Boost-Immunotherapy-Effectiveness/77600 2025-08-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/Pediatric-Antimicrobial-Stewardship-Challenges/77595 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/09-25/Sterile-Compounding-Robot-Efficiency/77604 2025-09-02 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Women’s-Health/Article/08-25/Diagnosing-and-Treating-Elusive-Postpartum-Psychosis/77598 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/Renin-Lactate-Levels-Key-to-Mortality-After-Refractory-Shock/77596 2025-07-24 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/08-25/New-Biosimilars-Metric-Confirms-Switching-Efficacy/77601 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/Choosing-the-Right-Agents-for-Sterile-Compounding-Cleanrooms/77730 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/5-Tips-for-Overseeing-Sterile-Compounding/77729 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/Gaps-and-Barriers-in-Sterile-Compounding-The-3-Ps/77728 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/ASHP-Report-Some-Generic-Drugs-A-Persistent-Source-of-Rx-Shortages/77590 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/DSCSA-Pharmaceutical-Supply-Chain-Enforcement/77602 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/08-25/Why-are-Fewer-Pharmacy-Residents-Completing-Their-Training/77589 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/2-Tools-for-Assessing-the-Validity-of-Online-Content/77714 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/HHS-and-Private-Health-Insurers-Team-Up-to-Improve-Prior-Authorization-Process/77695 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/02-26/Pharmacy-Medication-Reconciliation/77653 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/VYD2311-COVID-19-Antibody-Invivyd/77644 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/08-25/Lynozyfic-Approval-Multiple-Myeloma-Treatment/77643 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/08-25/RFK-Jr-Vaccine-Lawsuit-IDSA/77632 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/02-26/ASHP-Pharmacy-Futures-Gaps-Barriers-USP-797/77633 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/08-25/COVID-19-Impact-2025/77615 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/08-25/cefazolin-recall-sandoz-mispackaging/77608 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/08-25/Optimizing-Ig-Therapy-Through-Certification-and-Competency/77597 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/08-25/Pharmacist-Other-ID-Stakeholders-Slam-ACIP-Purge/77592 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/08-25/ASHP-2025-Pharmacy-Futures-Data-Integrity-Revenue-Cycle-Reimbursement-Payment-Insurance/77577 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/Evolving-340B-Program-Requires-Nimble-Administrators/77055 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/Rx-Shortage-Dashboard-Drives-Medal-Winning-Plan/77054 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/Allegheny-General-Hospitals-ADC-Journey/77053 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/AI-Tools-and-Vendors-Choose-Wisely/77051 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/08-25/Progress-Toward-the-Autonomous-Pharmacy-Hows-It-Going/77050 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/Keeping-an-Eye-on-New-Reimbursement-Trends/77534 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Pain/Article/08-25/ASHP-Pharmacy-Futures-Chronic-Pain-Management/77576 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/08-25/thimerosal-ACIP-flu-shots/77574 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/08-25/DEI-HOPA-Access-Representation/77573 2025-08-04 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Is-IVWMS-Adoption-Rate-Fast-Enough/77052 2025-07-29 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Pain/Article/07-25/With-Progress-New-Challenges-Emerge-in-Medication-Administration-in-the-OR/77439 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Know-When-to-Hold-Continue-Medications-in-the-Perioperative-Period/77440 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/acip-rsv-infants/77553 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/Immune-Globulins/77551 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Datroway-Lung-Cancer-Treatment/77547 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/07-25/ASHP-Pharmacy-Futures-Low-High-Level-Safety-Strategies/77544 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Infectious-Diseases/Article/07-25/ACIP-Delayed-Vaccination-Recommendations/77541 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/07-25/Mucormycosis-India-Mexico-Outbreaks-Covid-19/77530 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/FDA-Approves-Monjuvi-for-Relapsed-or-Refractory-Follicular-Lymphoma/77518 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Camber-Pharmaceuticals-Announces-Availability-of-Chlorpromazine-HCl-Injection-USP/77514 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/Yeztugo-FDA-Approved-HIV-PrEP/77492 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/ACIP-Weakened-Judge-Orders-NIH-Grants-Restored/77491 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Prefilled-Ketamine-Syringes-Coming-Soon/77489 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/07-25/Chronic-Graft-Versus-Host-Disease-Management/77436 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/DSCSA-Exception-Handling-Importance/77471 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Structured-Exercise-Improves-Survival-in-Stage-II-III-Colon-Cancer/77469 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Novel-Therapy-Found-Effective-for-Polycythemia-Vera-in-Phase-3-Trial/77468 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/New-Treatment-Strategy-Proposed-for-Some-Patients-With-HR-Positive-HER2-Negative-Advanced-Breast-Cancer/77467 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/Zusduri-Approved-for-Recurrent-Low-Grade-Intermediate-Risk-Non-Muscle-Invasive-Bladder-Cancer/77449 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Supporting-Nutrition-Patients-Throughout-Their-Treatment-Path/77315 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/Pembrolizumab-Approval-Head-Neck-Carcinoma/77450 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Pharmacy-Robotic-Automated-Systems/77056 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/07-25/Suzetrigine-Nonopioid-Acute-Pain/77317 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/07-25/Immunologic-and-Anaphylactoid-Reactions-in-Ig-Therapy/77318 2025-07-23 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/07-25/T-DXd-Pertuzumab-Breast-Cancer/77455 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Medication-Error-Rates-Benchmarking/77319 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Without-Normal-Vetting-R-F-K-Jr-Appoints-New-Folks-to-ACIP/77451 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Managing-In-House-Pharmacy-340B-Program/77316 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Integrative-Oncology-Herbal-Supplements/77313 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Gel-Reduces-Anti-EGFR-Rash/77320 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/Pharmacist-Burnout-Prevention-Strategies/77314 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/ADCs-Gynecologic-Malignancies-Management-Toxicities/77321 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/ICU-Altered-Mental-Status/77322 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Many-Ways-to-Guard-Against-Cyberattacks/77323 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/AI-Prescribing-Medications-Legislation/77324 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/07-25/Imfinzi-Immunotherapy-Gastric-Cancer/77433 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/FDA-Approves-Expanded-Indication-for-Mavyret-for-Acute-HCV/77413 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Pharmacists-Show-Their-Worth-in-Pediatric-Penicillin-Allergy-Delabeling/77410 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Pharmacist-Managed-Diabetes-Program-Significantly-Cuts-A1c-Levels/77409 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/FDA-Approves-Ibtrozi-for-ROS1-Positive-NSCLC/77407 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Humira-Biosimilar-Clinical-Success/77402 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Purge-of-ACIP-by-R-F-K-Jr-Condemned-by-PharmDs-MDs-and-Others/77389 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/FDA-Approves-Clesrovimab-Respiratory-Syncytial-Virus/77387 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Hot-340B-Topics-From-Winter-Coalition-Conference/77365 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Why-Are-Fewer-Pharmacy-Residents-Completing-Their-Training/77364 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Workflow-Assessment-Makes-the-Most-of-Sterile-Compounding-Robot-Productivity/77359 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/07-25/Medication-Safety-Good-Catches-Improvement/77356 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Sanofi-Beyfortus-Shipping-RSV/77362 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/-FDA-Approves-Nubeqa-for-Metastatic-Castration-Sensitive-Prostate-Cancer/77357 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/Hepatitis-C-Treatment-Funding-Senate-Bill-Cassidy-Chris-Van-Hollen/77348 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/Moderna-Avian-Influenza-Vaccine/77346 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Immunology/Article/07-25/FMT-Enhances-Immunotherapy-Effectiveness/77347 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/07-25/MAHA-Report-on-Childrens-Health-Distorts-Evidence-Experts-Say/77341 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Opinion/Immunology/Article/07-25/Pharmacists-Spring-Allergy-Management-Tips/77332 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/07-25/antibiotics-pipeline-sulopenem-tebipenem-cefepime-enmetazobactam/77327 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/07-25/Moderna-COVID-19-Vaccine-Approval/77326 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Recurrent-CDI-Strategies/77295 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Obesity-Impact-Beta-Lactam-Antibiotics-Treatment/77294 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/RDT-BSI-Biofire-Time-to-Therapy/77293 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Opinion/Article/07-25/So-You-Are-Being-Sued/77237 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/A-forall-Announces-First-U-S-Launch-of-Tromethamine-Injection-18-g-500-mL/77248 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Meitheal-Pharmaceuticals-Launches-Generic-Paclitaxel/77247 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Amneal-Launches-GLP-1-Agonist-Exenatide-Injection/77244 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Cancer-Cachexia-Treatment-Challenges/77027 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Malnutrition-Tests-Outpatient-Oncology/77029 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/07-25/Tariffs-Expected-to-Worsen-Shortages-Increase-Drug-Prices-and-Hurt-Healthcare/77240 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Nonoccupational-HIV-Post-Exposure-Prevention/77230 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Beyond-Pass-and-No-Pass-Making-Sampling-Data-Work-for-You/77227 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Parenteral-Nutrition-Order-Review/77028 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/07-25/COVID-Vaccine-Removed-CDC-Recommendations-Kids-Pregnancy/77221 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Enteral-Nutrition-Hemodynamically-Unstable-Patients/77030 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Trump-Executive-Orders-Pharmaceuticals/77219 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Insurance-Restrictions-Low-Reimbursement-Hitting-Pharmacies-on-GLP-1s/77212 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Preventing-Feeding-Tube-Occlusions-Strategies/77031 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/In-ICU-Early-Mobilization-Key-To-Achieving-Best-Outcomes/77032 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/07-25/Biosimilars-Patient-Access-Healthcare-Costs/77034 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Early-Real-World-Data-Positive-for-NMIBC-Immunotherapy/77033 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Immunology/Article/07-25/Immunoglobulin-Therapy-Aseptic-Meningitis-Syndrome/77035 2025-07-23 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Pharmacist-Gene-Therapy-Safety-Guidelines/77036 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Olanzapine-Found-Effective-for-Managing-TKI-Related-Side-Effects/77167 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Lets-Not-Forget-About-Revenue-Generating-Processes/77037 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Sterile-Compounding-Safety-Importance/77038 2025-07-17 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/VRBPAC-Recommends-New-SARS-CoV-2-Strain-for-Updated-COVID-19-Vaccines/77196 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Oncology-Pharmacists-Deemed-a-Valuable-Addition-to-Cancer-Care-Team/77026 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/New-FDA-COVID-Vaccine-Recs/77171 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/FDA-Approves-Welireg-PPGL-Treatment/77165 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/FDA-Approves-Zynyz-for-Squamous-Cell-Carcinoma-of-the-Anal-Canal/77160 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Cooperation-503A-503B-Compounders-Regulatory-Challenges/77039 2025-07-10 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/FDA-Approves-BLA-for-Novavaxs-COVID-19-Vaccine/77150 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Oncology/Article/07-25/Automated-Cancer-Patient-Follow-Up/77042 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/CDC-Accepts-ACIP-Vaccine-Recommendations-for-Chikungunya-Vaccine-Only/77142 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/AI-Benefits-Rural-Hospitals/77057 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/USPSTF-Updated-Guidance-for-Syphilis-Screening-During-Pregnancy/77137 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/Pharmacist-Burnout-Reduction-Strategies/77041 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Telemedicine-Substance-Use-Disorder/77043 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/07-25/Insulin-Infusion-Calculators/77044 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/AE-Reports-Prompt-FDA-CDC-to-Hit-Pause-on-Ixchiq-Vaccine/77129 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Targeted-Drug-Delivery-Scores-High-on-Patient-Satisfaction/77126 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Neuro-Ocular-and-Otic-Syphilis-Cases-Increase/77125 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/07-25/NFL-Opioid-Prescription-Monitoring-Program/77117 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Pharmacy-Cybersecurity-Priorities/77107 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/07-25/ASHP-Drug-Shortage-Report/77109 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/07-25/Pharmacist-Guidelines-Parenteral-Nutrition/77024 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/07-25/Trump-Tariffs-Pharmaceutical-Impact/77025 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/Sustainable-Healthcare-Diagnostic-Testing/77040 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Avutometinib-Defactinib-Combination-LGSOC-Treatment/77076 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Penpulimab-kcqx-Nasopharyngeal-Carcinoma-Treatment/77073 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/-First-and-Only-Ready-to-Dilute-Multi-Dose-Vial-of-Thiotepa-Approved/77067 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Healthcare-Data-Breach-Increase/77004 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Pharmaceutical-Compounding-Environmental-Sampling/77003 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Healthcare-AI-Safety-Concerns/77005 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/07-25/AXS25-Panel-Medically-Integrated-Dispensing-Is-Best-for-Oncology-Patients/77000 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/RFID-radio-frequency-identification-children-s-hospitals/76995 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/IDNs-Will-Use-AI-Other-Tools-to-Improve-Cell-and-Gene-Therapy/76994 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/07-25/Cryoablation-Abdominal-Surgery-Pain-Relief/76962 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-26/Tariffs-Market-Growth-on-Tap-at-Doug-Longs-AXS25-Summit-Swan-Song/76988 2026-01-09 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/HIV-Epidemic-Pharmacists-PrEP-Expansion/76932 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/07-25/Astronauts-Chronic-Back-Pain/76961 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Please-Dont-Stumble-on-These-4-Payment-Basics/76966 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/07-25/IG-Therapy-SARS-CoV-2-Antibody-Protection/76931 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Inflammatory-Diseases/Article/07-25/Infliximab-Maintenance-Therapy-Immunosuppressant/76963 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/7-Strategies-for-RFID-Success/76956 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/GLP-1-Receptor-Agonists-Surgery-Guidelines/76929 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/6-Steps-That-Could-Spur-Higher-RFID-Implementation/76955 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Lessons-Learned-from-2-RFID-Veterans/76954 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Medication-Safety-Best-Practices/76928 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Oncology/Article/07-25/Teledermoscopy-Melanoma-Diagnosis-Technology/76927 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/CDC-Chikungunya-Vaccine-Adoption/76937 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Melanoma-Survivor-Sun-Protection/76661 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/07-25/Vanrafia-Accelerated-FDA-Approval-IgA-Nephropathy/76926 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/07-25/Trump-Executive-Order-Drug-Prices/76924 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Lumicera-Health-Services-Partners-With-Costco-Pharmacy-for-Cost-Plus-SP-Services/76921 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/07-25/Ensitrelvir-COVID-19-Prevention-Efficacy/76656 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/07-25/Anticoagulation-End-of-Life-Management-Considerations/76657 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/Stress-Ulcer-Prophylaxis-Guidelines-Recommendations/76659 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/ICU-Sedation-Protocols-Expert-Panel/76660 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/GLP-1-Lilly-FDA-Lawsuit/76663 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Article/07-25/Medication-Errors-Year-in-Review/76883 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/Reimbursement-Matters-Health-System/76664 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/07-25/Promoting-Professional-Identity-Combats-Burnout/76662 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/ACIP-Recommends-Expanded-Use-for-RSV-Vaccines/76864 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/ACIP-Recommends-GSKs-5-in-1-Meningococcal-Vaccine/76863 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Better-Clinical-Outcomes-Seen-With-Fetroja-as-Empiric-Not-Salvage-Therapy/76859 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/07-25/IV-Waste-Reduction-Strategies/76665 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/07-25/AI-Predicts-Fluid-Overload/76666 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/07-25/Telecritical-Care-Building-Rapport/76667 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/ASHP-ShiftRx-Pharmacy-Staffing/76845 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/07-25/Insulin-Infusion-Calculators-Cleveland-Clinic/76840 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/IL-6-Promising-Biomarker-for-Diagnosing-Sepsis-Early/76838 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/07-25/Oral-Ensitrelvir-Protects-Against-COVID/76837 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Opdivo-With-Yervoy-HCC-Treatment-Approval/76832 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/07-25/When-Illicit-Drugs-Crash-the-Party-ED-Pharmacists-Have-the-Antidotes/76655 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/Tariffs-Pharmaceutical-Impacts/76825 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/07-25/Overcoming-Pain-Care-Stigma/76654 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Adjuvant-Nivolumab-Bladder-Cancer-Effective/76658 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/07-25/Survivorship-Planning-for-Melanoma-Patients/76562 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Opdivo-with-Yervoy-Colorectal-Cancer-Approval/76802 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/07-25/NIH-Funding-Cuts-Impact/76758 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/07-25/Qfitlia-FDA-Approval-Hemophilia-Treatment/76745 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/07-25/ID-and-Public-Health-Experts-You-Just-Cant-Replace-Federal-Expertise/76742 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/07-25/Gene-Therapy-Occupational-Safety/76734 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Amneal-Boruzu-Subcutaneous-Formulation-Launch/76739 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/07-25/Meitheal-Pharmaceuticals-Announces-Approval-and-Launch-of-Liraglutide-Injection/76735 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/07-25/Pluvicto-Expansion-Prostate-Cancer/76727 2025-07-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/04-25/Tips-for-Avoiding-Medication-Related-Feeding-Tube-Clogs-Discussed-at-ASPEN-Conference/76595 2025-04-01 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/04-25/sulbactam-durlobactam-crab-antimicrobials-antimicrobial-resistance/76702 2025-04-01 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/04-25/Imfinzi-Bladder-Cancer/76732 2025-04-02 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Category-3-Compounding-Safety-Standards/76519 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Emotional-Intelligence-Sterile-Compounding-Training/76518 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/IV-Waste-Reduction-Strategies/76520 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Centralized-Media-Fill-Program-Benefits/76521 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-First-in-Class-Blujepa-to-Treat-uUTIs-in-Females-12-and-Older/76627 2025-03-27 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Egrifta-WR-to-Treat-Excess-Visceral-Abdominal-Fat-in-Adults-With-HIV/76626 2025-03-27 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Sterile-Compounding-Designated-Person/76517 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/03-25/Cabometyx-Approval-Pancreatic-Neuroendocrine-Tumor/76614 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Grants-Third-Indication-to-Fabhalta-for-C3G/76609 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Plan-Ahead-for-Ongoing-PN-Component-Shortages/76607 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/03-25/HIV-Drugs-Weight-Gain-CROI-2025/76604 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Cleanroom-HVAC-Engineering-Concepts/76522 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/03-25/HIV-HBV-Coinfection-Bictegravir-CROI-2025/76602 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/03-25/10-Compounding-Safety-Strategies/76523 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/03-25/Malnutrition-Monitoring-Ambulatory-Cancer-Clinics/76601 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/03-25/Responding-to-NIOSH-Hazardous-Drugs-Update/76516 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/03-25/Hazardous-Drug-Residue-Monitoring/76515 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Infectious-Diseases/Article/03-25/Cabotegravir-Rilpivirine-HIV-Treatment-CROI-2025/76597 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/03-25/Pharmacist-Advancements-Parenteral-Nutrition/76596 2025-03-25 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-25/Meitheal-Pharmaceuticals-Launches-Alprostadil-Injection-USP-in-Vial-Form/76594 2025-03-24 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/03-25/antimicrobials-antibiotics/76590 2025-03-24 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Every-1-in-NIH-Research-Funding-Returns-2-56-to-the-U-S-Economy/76585 2025-03-24 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/03-25/Pharmacists-Play-Important-Role-in-Sun-Safety-Education/76577 2025-03-24 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/03-25/AI-Medication-Cluster-Prediction/76559 2025-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Polypharmacy-Cancer-Adults-Prevalence/76474 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/Keytruda-Receives-Traditional-Approval-for-Some-Patients-With-HER2-Positive-Gastric-or-GEJ-Adenocarcinoma/76564 2025-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/Just-Say-No-to-Paying-Cybersecurity-Ransom/76476 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/03-25/Pediatric-Parenteral-lipid-injectable-emulsions/76551 2025-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/DEA-Warns-of-EHR-Hacking-Fraud/76477 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Higher-Case-Counts-More-Serious-Illness-in-Puerto-Rico-Dengue-Outbreak-CDC-Issues-Alert/76547 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/03-25/Excellence-Medication-Safety-Certification/76479 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Take-a-Closer-Look-at-340B-Spend-Data/76482 2025-03-19 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Hospital-Pharmacy-Transitions-Challenges/76478 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Recommends-Influenza-Vaccine-Composition-for-the-2025-2026-U-S-Influenza-Season/76538 2025-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Women’s-Health/Article/03-25/Young-Women-Breast-Cancer-Empowerment/76470 2025-03-18 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Bavarian-Nordic-Launches-Chikungunya-Vaccine/76535 2025-03-18 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/03-25/Medication-Errors-Dose-Quantity-Safety/76481 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/A-Professional-Tidal-Wave-of-Opportunities-and-Challenges/76484 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Specialty-Pharmacies-Reducing-Medication-Nonadherence/76483 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/Ethical-Drug-Shortages-Dilemma/76466 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Integrative-Oncology-Modalities-Importance/76473 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Rybrevant-Lazcluze-Lung-Cancer/76472 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Label-Changes-for-Buprenorphine-ER-Injection/76514 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Voraxaze-Improves-Methotrexate-Nephrotoxicity-Recovery/76469 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Inflammatory-Diseases/Article/03-25/Adalimumab-Biosimilar-Differentiation/76485 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/Breast-Cancer-Disparities-and-Black-Women/76471 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Weldons-Nomination-to-Head-CDC-Withdrawn/76511 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/03-25/Compounding-Pharmacies-GLP-1-Compliance-Challenges/76486 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/03-25/503B-Vendor-Evaluation-Crucial/76480 2025-03-28 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Critical-Care/Article/03-25/2024-s-Emergency-Medicine-Pearls/76475 2025-03-13 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Mpox-Outbreak-Uganda-varicella-zoster-CROI-2025/76500 2025-03-13 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Tecovirimat-Clinical-Trial-Results/76499 2025-03-13 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/03-25/Ensitrelvir-Reduced-the-Risk-for-COVID-19-by-67/76498 2025-03-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/05-25/Breast-Cancer-Treatment-Advances/76468 2025-05-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/A-Good-Year-for-CAR-T-Therapies/76467 2025-03-13 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Article/03-25/Parenteral-Nutrition-Therapy/76465 2025-03-18 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/03-25/Top-Hazards-for-Pharmacy-Tech/76431 2025-03-06 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-First-Interchangeable-Omalizumab-Biosimilar/76452 2025-03-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Measles-Death-New-Mexico/76450 2025-03-07 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Article/03-25/Pemivibart-Monoclonal-Antibody-COVID/76449 2025-03-07 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Clears-Second-QIAstat-Dx-Mini-GI-Rapid-Diagnostic-Test/76447 2025-03-07 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Measles-Vaccination-Importance-Advocacy/76435 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/New-Legal-Weapons-Against-GLP-1-Compounders-Emerge/76433 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/03-25/AI-Critical-Care-Pharmacy/76422 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/03-25/Tevimbra-FDA-Approval-ESCC/76409 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/03-25/GLP-1-Agonists-SGLT2-Inhibitors-Preoperative-Withholding/76402 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/03-25/Telecritical-Care-Pharmacist-Role/76398 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/FDA-Vaccine-Advisory-Committee-Meeting-Canceled/76394 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/First-U-S-Measles-Death-in-10-Years-Reported-in-Texas-Outbreak/76355 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Is-It-Safe-to-De-escalate-Antibiotics-in-Sepsis-Patients/76345 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Pharmacy-Staff-Burnout-Solutions/76348 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Calcium-Often-Not-Helpful-After-Cardiac-Arrest/76346 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Effective-Sepsis-Treatments-Continue-to-Evolve/76344 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Theres-Really-No-Debate-Lightly-Sedate-Whenever-Possible/76341 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/Chenodiol-FDA-Approval-CTX-Treatment/76335 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/FDA-Declares-End-to-Semaglutide-Shortage-Clock-Ticking-on-Compounded-Versions/76337 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Sepsis-Tips-for-Early-Identification-and-Home-Based-Prevention/76325 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Primary-Immunodeficiency-Treatment-and-Support/76324 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/ACIP-Meeting-Postponed/76317 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Hematology/Article/03-25/Darzalex-Delays-Multiple-Myeloma-Transition/76307 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/03-25/FDA-Approves-Romvimza-Giant-Cell-Tumor/76305 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-25/Mesalamine-Launch-Amneal/76314 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/03-25/Adcetris-Lymphoma-Treatment-Approval/76303 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/Gomekli-Approved-for-Patients-With-Neurofibromatosis-Type-1/76301 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-25/Long-Grove-Pharmaceuticals-Joins-Growing-Call-for-Drug-Label-Improvements/76309 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/03-25/FDA-Approves-First-Chikungunya-Vaccine-for-People-as-Young-as-12-Years-of-Age/76289 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/03-25/FDA-Approves-Penmenvy-GSKs-5-in-1-Meningococcal-Vaccine/76287 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Senate-Confirms-RFK-Jr-as-Health-Secretary/76245 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/03-25/Compounding-Pharmacies-Inspections-GLP-1-Demand/76242 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Inflammatory-Diseases/Article/03-25/Basics-and-Benefits-of-Biosimilars-A-Rheumatologists-Take/76241 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/ASHP-Urges-Tariff-Exemptions-for-Medications-and-APIs-to-Prevent-Price-Increases-Drug-Shortages/76236 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/03-25/Managing-Respiratory-Distress-Symptoms-in-People-with-Lung-Cancer/76234 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/03-25/Signals-From-Lungs-of-Cancer-Patients-May-Cause-Thrombosis/76233 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/03-25/High-Rates-of-Polypharmacy-Among-Lung-Cancer-Patients-Even-Younger-Adults/76232 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Judge-Orders-HHS-CDC-and-FDA-to-Restore-Deleted-Web-Pages/76227 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/03-25/Pharmacy-Board-Labeling-Regulations/76174 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/Decreasing-Postoperative-Adverse-Events-and-Waste-Costs-With-Low-Dose-Opioid-And-Ready-to-Administer-RTA-Medications/76214 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Emblaveo-to-Treat-Certain-Complicated-Intraabdominal-Infections/76210 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Court-Grants-Temporary-Restraining-Orders-Against-NIH-Funding-Cuts/76208 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Specialty-Pharmacy-Healthcare-Trends/76175 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Hematology/Article/03-25/Chronic-Lymphocytic-Leukemia-Treatment-Management/76176 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Cardiology/Article/03-25/Rheumatoid-Arthritis-Glucocorticoid-Treatment-Guidelines/76177 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/03-25/Parenteral-Nutrition-Shortage-Management/76178 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Some-CDC-HIV-Web-Content-Gets-Restored-But-Gaps-Remain/76202 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Women’s-Health/Article/03-25/Pharmacist-Abortion-Access-Washington/76179 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/03-25/Horseshoe-Crab-Sustainability-Concern/76171 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/NIOSH-Hazardous-Drugs-2024-List/76173 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Hospital-Compliance-USP-Regulations-Care/76180 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Medication-Safety/Article/03-25/Joint-Commission-Medication-Safety-Changes/76172 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Finance-Committee-Sends-RFK-Jr-Nomination-for-Full-Senate-Vote/76196 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/04-25/Reimbursement-of-Wasted-Drugs-CMS/76181 2025-04-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/03-25/Purdue-Pharma-New-Settlement/76194 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Medication-Safety/Article/03-25/FDA-Smartphone-Diabetes-Alerts/76191 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/03-25/Somerset-Launches-4-New-Ophthalmics-Products/76185 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/RFID-Technology-Hospital-Pharmacies/76182 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/03-25/Drug-Shortages-Data-Analytics/76152 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/Government-Purge-of-CDCs-HIV-Web-Content-Alarms-ID-Pharmacists-and-Other-Experts/76125 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/03-25/FDA-Approves-Novel-Nonopioid-Treatment-for-Moderate-to-Severe-Acute-Pain/76120 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/03-25/Despite-Lawsuits-Books-and-Tweets-RFK-Jr-Still-Saying-He-Is-Not-an-Anti-Vaxxer/76115 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/03-25/Telepharmacy-Advantages-Home-Health/76112 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/03-25/ASHP-Pharmacy-Forecast-Hospital-Trends/76099 2025-03-26 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/02-25/Camber-Pharmaceuticals-Introduces-Sirolimus-Oral-Solution/76098 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/02-25/Swisslog-Healthcare-Announces-Robotics-Partnership-With-BD/76082 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-25/As-HHS-Secretary-Could-RFK-Jr-Actually-Damage-the-U-S-Vaccine-Program/76064 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Health-System-Specialty-Pharmacies-Improve-Adherence/76056 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/02-25/Pharmacist-Led-HCV-Micro-Elimination-Program/76046 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Public-Health-Experts-Criticize-WHO-Withdrawal/76042 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Women’s-Health/Article/02-25/Datopotamab-Deruxtecan-Dlnk-Approval-Breast-Cancer/76039 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-25/Pharmacy-Comes-Full-Circle-as-Site-of-Care/76027 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Medication-Safety/Article/02-25/FDA-Alert-Highlights-Smart-Pump-Software-Anomalies/76026 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/02-25/FDA-Approves-Lumakras-With-Vectibix-for-KRAS-G12C-Mutated-Colorectal-Cancer/76018 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/02-25/FDA-Approves-Calquence-With-Bendamustine-and-Rituximab-for-Previously-Untreated-Mantle-Cell-Lymphoma/76021 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/FDA-Warns-Healthcare-Professionals-Not-to-Use-Epinephrine-Nasal-Solutions-From-BPI-Labs-and-Endo-USA/76013 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/CDC-Issues-Health-Alert-Subtype-Influenza-A-Among-Hospitalized-Patients/76003 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/02-25/Rise-in-Breast-Cancer-Among-Young-Women-Requires-New-Models-of-Care/75931 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/02-25/Is-Breast-Cancer-Metastasis-a-Hereditary-Disorder/75932 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Women’s-Health/Article/02-25/Environmental-Exposure-a-Risk-Factor-for-Breast-Cancer/75930 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Breast-Cancer-Population-Based-Genetic-Testing-Versus-Guideline-Based-Screening/75928 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/02-25/Trump-Administration-340B-Program/75923 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/04-25/Reimbursement-Matters-Health-System/75922 2025-04-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Avian-Flu-Control-Challenges/75987 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Oncology/Article/02-25/UNC-Pharmacy-Biomarker-Cancer-Treatments/75924 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/02-25/Despite-Risks-and-Scant-Evidence-Muscle-Relaxants-Still-Used-to-Treat-Chronic-Pain/75988 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/02-25/FDA-Requires-GBS-Warning-for-RSV-Vaccines/75986 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/02-25/Automated-Dispensing-Cabinets-Safety/75921 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/GI-Disorders/Article/02-25/Tevimbra-Approved-for-Treatment-of-Gastric-and-Gastroesophageal-Junction-Cancers-in-Combination-With-Chemo/75967 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-25/Pharmacist-Inpatient-Billing-Challenges/75920 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Breakthrough-in-EGFR-Mutated-NSCLC-Rybrevant-Plus-Lazcluze-Extends-Overall-Survival/75964 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Glucarpidase-Boosts-Recovery-From-Methotrexate-Induced-Acute-Kidney-Injury/75961 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Immunology/Article/02-25/Safe-Travel-Organ-Transplant/75917 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-25/Healthcare-Worker-Burnout-Prevention/75916 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-25/Hospital-Pharmacy-Audit-Stressors/75915 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/02-25/Nutrition-Support-Patient-Survey/75919 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Health-Systems-Specialty-Medications-Revenue/75929 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Hematology/Article/02-25/CLL-SLL-Treatment-Landscape-Evolution/75918 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/02-26/Malnutrition-Awareness-Week-Presenters-Discuss/75927 2026-02-06 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Vaccination-for-Respiratory-Viruses-Lags/75847 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/02-25/Flu-Increasing-Across-U-S/75846 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/02-25/Specialty-Pharmacists-Data-Mine-EHRs-To-Boost-Oncology-Drug-Adherence/75835 2025-02-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-25/IRA-Reduces-Specialty-Pharmacy-Reliance-on-Patient-Assistance-Programs/75833 2025-01-02 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-25/Just-Say-No-to-Paying-Cybersecurity-Ransoms/75832 2025-01-02 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/01-25/FDA-Approves-Opdivo-Qvantig-for-Subcutaneous-Injection/75809 2025-01-02 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/12-24/FDA-Accepts-for-Priority-Review-Nuvation-Bios-NDA-for-Taletrectinib-to-Treat-Advanced-ROS1-positive-Non-Small-Cell-Lung-Cancer/75806 2024-12-27 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/12-24/RFID-Future-Hospital-Pharmacy/75780 2024-12-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/Zepbound-Approved-for-Obstructive-Sleep-Apnea/75794 2024-12-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/FDA-Declares-End-to-Tirzepatide-Shortage/75792 2024-12-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Effective-Corticosteroid-Treatment-cGVHD-Alternative/75735 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Harnessing-the-Potential-of-CAR-T-Cell-Therapy-for-Multiple-Myeloma/75734 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/NIOSH-Releases-Updated-List-of-Hazardous-Drugs-in-Healthcare-Settings/75789 2024-12-20 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/12-24/Pharmacy-Technology-AI-Solutions/75779 2024-12-19 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/12-24/FDA-Approves-Ryoncil-for-SR-aGVHD/75778 2024-12-19 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/FDA-Approves-Ensacove-for-ALK-Positive-Locally-Advanced-or-Metastatic-NSCLC/75771 2024-12-19 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/12-24/Bluesight-Medication-Intelligence-Expansion/75768 2024-12-19 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Specialty-Pharmacy-Market-Trends/75729 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Hematology/Article/12-24/Gene-Therapy-Cost-Savings/75726 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/FDA-Approved-Unloxcyt-Skin-Cancer/75760 2024-12-16 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/12-24/GLP-1-Agonists-FDA-Scrutiny-Dodge/75725 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/01-25/NSCLC-Therapeutics-Promising-Approvals-2024/75724 2025-01-06 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/01-25/Collaborative-Practice-Agreement-Reduces-Time-to-PrEP-Access/75754 2025-01-10 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/Healthcare-Worker-Burnout-Strategies/75750 2024-12-16 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/AI-Pharmacy-Staffing-Solutions/75676 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/12-24/Solid-Organ-Transplant-Maintenance-Immunossuppression/75679 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/12-24/Future-Bright-Oncology-Development/75678 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Medication-Safety/Article/12-24/DOAC-Prescribing-Support-Tool/75675 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/12-24/Troubleshooting-Steps-Needed-Now-For-2025-Supply-Chain-Enforcement/75673 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Act-Now-on-6-IV-Fluid-Conservation-Strategies/75677 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Pharmacogenomics/Article/12-24/Specialty-Pharmacy-Set-To-Meet-the-Challenges-Of-PGx-Clinical-Integration/75672 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/Blinatumomab-Increases-Disease-Free-Survival-for-Children-With-Leukemia/75719 2024-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/ISMP-Attending-to-Human-Factors-Would-Increase-Medication-Safety/75718 2024-12-11 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/12-24/Optimizing-Medication-Management-for-505-b-2-Drugs/75717 2024-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-24/Empiric-Antibiotic-Choices-for-Diabetic-Foot-Infections-Often-Discordant-With-Risk-Factors/75716 2024-12-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/12-24/Precision-Oncology-Effort-Blooms-in-North-Carolina/75710 2024-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/Building-the-Case-for-a-Centralized-Media-Fill-Program/75708 2024-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/Inconsistent-Progress-Toward-2030-Pharmacy-Goals-ASHP-Survey-Shows/75706 2024-12-10 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/GLP-1s-Contribute-to-Lower-Risk-for-VTE-in-Patients-With-Diabetes/75684 2024-12-09 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/12-24/Manager-Strategies-For-Alleviating-Staff-Crisis-in-Compounding/75674 2024-12-13 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/12-24/Syphilis-Epidemic-Treatment-Options-drug-shortages-STIs/75666 2024-12-06 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/12-24/REMS-Compliance-Challenges-Solutions/75667 2024-12-06 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/Imfinzi-Approval-Small-Cell-Lung-Cancer/75658 2024-12-05 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/12-24/Bizengri-FDA-Approval/75656 2024-12-05 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/12-24/Enhancing-Patient-Safety-Through-Critical-Drug-Label-Improvements/75647 2024-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/12-24/Elderly-Polypharmacy-Deprescribing-Pharmacists/75624 2024-12-03 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/12-24/IRS-Guidance-Improves-Medication-Adherence/75621 2024-12-02 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Women’s-Health/Article/12-24/Contraceptive-Care-Access-Recommendations/75590 2024-12-02 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/12-24/Baxter-Restarts-Some-IV-Solutions-Manufacturing-ISMP-Issues-Guidance-for-Imported-IV-Products/75330 2024-12-02 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Hematology/Article/11-24/Hemophilia-Gene-Therapy-Developments/75472 2024-11-27 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/11-24/How-to-Avoid-Groundhog-Day-Syndrome-When-Dealing-With-Hazardous-Drugs/75470 2024-11-27 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/03-25/Medication-Errors-The-Year-in-Review/75473 2025-03-20 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Biosimilars/Article/11-24/Pharmacists-Key-Role-in-The-Management-of-Humira-Biosimilars/75471 2024-11-27 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/11-24/Ziihera-Approval-HER2-Positive-Biliary-Tract-Cancer/75591 2024-11-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Beer-Drinkers-Lower-Quality-Diet-liver-disease-alcohol/75569 2024-11-26 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Biktarvys-Benefits-Extend-in-Older-Adults-With-HIV/75568 2024-11-26 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/11-24/Biosimilar-Formulary-Standardized-Approach/75543 2024-11-25 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/11-24/Addressing-IVWMS-Workarounds/75469 2024-11-22 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Avian-Influenza-H5N1-California/75532 2024-11-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Second-Trump-Administration-Impact-on-340B-Program-to-Be-Determined/75523 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/RZV-Prevents-Shingles-in-Adults-With-Autoimmune-Diseases/75520 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/CNS-Involvement-in-Immunocompromised-Shingles-Patients-Dont-Miss-the-Subtle-Signs/75519 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Candida-Auris-Public-Health/75398 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/11-24/A-War-Brewing-Over-GLP-1-Agonist-Production/75409 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Benefits-of-Shingles-Vaccine-Outweigh-Risks-for-the-Immunocompromised/75518 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Oncology/Article/11-24/Holistic-Oncology-Specialty-Pharmacists/75403 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Pulmonology/Article/11-24/Promise-and-Hurdles-In-Personalized-Medicine/75404 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/11-24/Counterfeit-Drug-Dangers-Online/75410 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Rapid-Molecular-Panel-ABx-Reduction/75399 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Specialty-Pharmacy-Success-Stories/75405 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Inflammatory-Diseases/Article/11-24/SP-Pharmacist-Led-ED-Program-Boosts-Hepatitis-C-Treatment/75406 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/NASP-Urges-Action-on-Abysmal-Medicare-Part-D-Reimbursement/75408 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/12-24/Short-Course-Antimicrobial-Therapy-Effectiveness/75394 2024-12-04 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Oncology/Article/11-24/Drug-Labeling-for-Fludarabine-Phosphate-Updated-Under-FDAs-Project-Renewal/75510 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Inflammatory-Diseases/Article/11-24/RA-Pregnancy-Heart-Complications/75401 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Oncology/Article/11-24/STAQ-Pharma-Oncology-Collaboration/75412 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/A-Period-of-Uncertainty-Looms-for-GLP-1-Compounders/75506 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Endocrinology/Article/11-24/Machine-Learning-Obesity-Treatment-Prediction/75414 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Vaccination/Article/11-24/Pneumococcal-Conjugate-Vaccines-Recommendation/75402 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pain/Article/11-24/Ibuprofen-Injection-Shows-Better-Real-World-Outcomes-in-Comparative-Study/75497 2024-11-19 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/NOPAIN-Act-to-Embrace-Seniors-in-Medicare-Part-D-Reimbursement-for-Nonopioid-Alternatives/75496 2024-11-19 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/California-Confirms-First-Clade-I-Mpox-Case/75495 2024-11-19 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/11-24/Pharmacist-Managed-Remote-HF/75411 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/Drug-Compounding-Facilities-Extension/75395 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/12-24/Demystifying-Deprescribing-Provider-and-Patient-Buy-in-Is-Key/75393 2024-12-04 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/11-24/Revumenib-FDA-Approval-Leukemia-Treatment/75479 2024-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Medication-Safety/Article/11-24/IVWMS-Workarounds-Pharmacy-Safety/75413 2024-11-18 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/11-24/Biosimilar-Uptake-Remains-Variable/75407 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/04-25/Catching-Up-With-Coding-Updates/75415 2025-04-29 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/02-25/Toward-a-More-Environmentally-Sustainable-Cold-Chain/75417 2025-02-10 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/11-24/Optimal-Antimicrobial-Stewardship/75418 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Biosimilars/Article/11-24/Biosimilar-Treatment-Inflammatory-Diseases/75397 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Is-AI-the-Patient-and-Staff-Support-Program-of-the-Future/75449 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/AI-Poised-to-Improve-Trial-Recruitment-and-Drug-Adherence-in-Specialty-Pharmacy/75447 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/A-History-of-Pharmacy-as-a-Profession/75416 2024-11-14 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/11-25/Pharmacist-Inclusion-Benefits-Patients-With-Opioid-Use-Disorder/75400 2025-11-20 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/11-24/FDA-Approves-Aucatzyl-for-Adults-With-Relapsed-or-Refractory-B-Cell-Precursor-ALL/75426 2024-11-12 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Cardiology/Article/11-24/Pharmacists-Key-Players-on-AFib-Treatment-Teams/75396 2024-11-12 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/After-Latest-DSCSA-Reprieve-Experts-Offer-Tips-for-Navigating-New-Deadlines/75392 2024-11-12 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Improving-HBV-Screening-Before-Switching-to-2-Drug-HIV-Regimens/75384 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/How-to-Avoid-Groundhog-Day-Syndrome-When-Dealing-With-Hazardous-Drugs/75419 2024-11-12 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Tips-for-Easing-the-Sterile-Compounding-Staffing-Crisis/74108 2024-11-11 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Ensuring-Hazardous-Drug-Safety-a-Team-Approach/74104 2024-11-11 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Drug-Information-Specialists-Offer-Practical-Tips-for-Combating-Misinformation/75390 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Immigrants-With-Chronic-HBV-Are-Vulnerable-to-Lapses-in-Antiviral-Use/75380 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Review-Articles/Article/11-24/Hepatitis-B-and-HIV-Coinfection/75379 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Webinar-Offers-Guidance-on-Preparing-for-DEA-Diversion-Inspections/75377 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/How-a-GLP-1-Shadow-System-Puts-Patients-Safety-at-Risk/75304 2024-11-07 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Sepsis-Core-Elements-Program-Drives-Improvements/75357 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/10-24/Asciminib-Approval-Chronic-Myeloid-Leukemia/75320 2024-10-31 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-24/CDC-Recommends-Second-Dose-of-2024-2025-COVID-19-Vaccine-for-Older-or-Immunocompromised-People/75310 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/Need-a-DSCSA-Pause-Heres-How-to-File-An-Effective-WEE-Form/75028 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pulmonology/Article/10-24/Biologics-Hit-Multiple-Targets-in-Asthma-and-COPD/75030 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/People-in-Pharmacy/Article/10-24/On-the-Front-Lines-Of-Preparedness-A-Career-in-Pharmacy/75027 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-24/A-History-of-Pharmacy-as-a-Profession/75032 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Twice-Yearly-Lenacapavir-Sets-a-New-PrEP-Standard/75031 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Medication-Safety/Article/10-24/Mitigating-the-Risks-From-Sudden-Admixture-Shortages/75033 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Pharmacist-Led-HCV-Treatment-Success/75224 2024-10-21 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-24/The-Proposed-CY-2025-OPPS-ASC-and-PFS-Payment-Rules/75034 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-24/Rapid-Multiplexed-Molecular-Panel/75268 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-24/After-Latest-DSCSA-Reprieve-Experts-Offer-Tips-for-Navigating-New-Deadlines/75265 2024-10-25 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/HSSPs-Avoid-Unnecessary-Costs-Through-Meaningful-Interventions/75036 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/After-Helene-Damage-FDA-Grants-Compounding-Flexibility-for-IV-Solutions-During-Shortage/75247 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/11-24/Counterfeit-Drugs-Online-Pharmacies/75245 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/ACIP-PCV-Vote-50/75242 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Patient-Experience-a-Growing-Target-for-Tech-Solutions/75037 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/11-24/Expanding-CDK4-6-Inhibitors-to-Early-Stage-Breast-Cancer/75222 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Rigorous-Real-World-Evidence-Should-Inform-Formulary-Decisions/75232 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Oncology-Pipeline-Exciting-Breakthroughs-Cited-at-AMCP-Nexus-2024/75231 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/FDA-Inspections-Waivers-Amid-Top-Concerns-as-DSCSA-Looms/75223 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/11-24/Vyloy-With-Chemotherapy-Approved-for-Gastric-or-Gastroesophageal-Junction-Adenocarcinoma/75221 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Oncology/Article/11-24/Oral-Oncolytics-Adverse-Events-Monitoring/75185 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Medication-Safety/Article/01-25/Video-Specialty-Pharmacy-Disaster-Plans/75207 2025-01-09 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/11-24/Proposed-FDA-Rule-Could-Enable-POC-Hepatitis-B-Testing/75206 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/radio-frequency-identification/75204 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/11-24/Pharmacist-Recommendations-Improve-Hepatitis-B-Screening-in-Oral-Oncology-Patients/75203 2024-11-06 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/11-24/Late-Diagnosis-Complicates-Chronic-Hepatitis-B/75202 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/11-24/Pediatric-Antibiotic-Prescribing/75200 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Infectious-Diseases/Article/11-24/Tennessee-HIV-Funding-Rejection-Consequences/75199 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Pharmacy-Modernizes-but-Where-Is-Provider-Status/75035 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pharmacogenomics/Article/01-25/Bringing-Diversity-to-Pharmacogenomics/75029 2025-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pharmacogenomics/Article/11-24/Promise-and-Hurdles-in-Personalized-Medicine/75190 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Industry-News/Article/11-24/Premier-and-Long-Grove-Partner-to-Increase-Norepinephrine-IV-Bag-Supply/75184 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Quantifying-the-Cost-of-Specialty-Pharmacist-Interventions-for-Outside-Prescriptions/75178 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/11-24/Holistic-Oncology-and-Specialty-Pharmacists/75177 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Critical-Care/Article/11-24/Machine-Learning-Can-Aid-in-Sepsis-Identification/75163 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/The-NOPAIN-Act-Clinical-and-Financial-Opportunities-in-Hospital-Outpatient-and-Ambulatory-Settings/75138 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/11-24/NASP-Urges-Action-on-Abysmal-Medicare-Reimbursement/75157 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/FDA-Grants-Reprieve-on-Enhanced-DSCSA-Requirements-With-New-Phased-In-Deadlines/75146 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Breathing-New-Life-Into-the-NSCLC-Pipeline/75134 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/-Tail-Period-for-Compounders-Could-Ease-Weight-Loss-Rx-Shortages/75130 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Biosimilar-Uptake-Remains-Variable-Posing-Challenges-to-the-Market/75127 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/11-24/Conserving-IV-Fluids-Critical-as-Hurricane-Flooding-Damages-Key-Facility/75124 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Article/11-24/Mitigating-Inequities-Language-is-the-Road-to-Better-Health/75097 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/FDA-Lagging-in-Pharmaceutical-Facility-Inspections-Could-Affect-Drug-Shortages/75096 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/11-24/Building-a-Temple-to-Better-Specialty-Care/75091 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/11-25/Semaglutide-Improves-Kidney-Disease-and-Diabetes-Outcomes/75038 2025-11-20 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Endocrinology/Article/11-24/FDA-and-State-Boards-Eye-GLP-1s-Amid-Larger-Compounding-Scrutiny/75026 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/11-24/FDA-Approves-Neoadjuvant-Adjuvant-Opdivo-for-Resectable-NSCLC/75067 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Hospital-Pharmacy-Technology-Solutions/74771 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/11-24/Preventing-ADC-Medication-Errors/74772 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Biosimilars/Article/11-24/Pharmacists-Key-in-Supporting-Biosimilar-Uptake/75062 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Opinion/Article/11-24/3-Reasons-Why-Pharmacies-and-Labs-Should-Partner/75039 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/Parenteral-Nutrition/75058 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/11-24/Achieving-Success-With-IV-Room-Verification-Technology/74774 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Cardiology/Article/11-24/Wearable-ECG-Monitoring-Pharmacists-Essential/75041 2024-11-05 monthly 0.6 https://www.pharmacypracticenews.com/Multimedia/Hematology/Article/10-24/heparin-resistance-antithrombin-deficiency-venous-thromboembolism-antithrombin-concentrate/74999 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/AI-Tools-Pharmacy-Education/74775 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/AI-Specialty-Pharmacy-Potential/74776 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Pharmacy-Graduation-Decline-Concern/74777 2024-11-20 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/FDA-Fully-Approves-Retevmo-for-RET-Fusion-Positive-Medullary-Thyroid-Cancer/74997 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Artificial-Intelligence-Can-Improve-Medication-History/74778 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Compliance/Article/10-24/10-Tips-for-Home-Infusion-Accreditation-Inspection/74946 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Compliance/Article/10-24/Whats-Your-EQ-Using-Emotional-Intelligence-in-Sterile-Compounding-Training/74947 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Hematology/Article/10-24/Sickle-Cell-Drug-Oxbryta-Withdrawn-From-Market/74963 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/GI-Disorders/Article/10-24/fecal-microbiota-transplant-UC-upadacitinib-Crohn-s-Miguel-Regueiro/74888 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/10-24/FDA-Approved-Levacetylleucine-NPC-Treatment/74957 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/Tagrisso-Approved-for-Some-With-Locally-Advanced-Unresectable-Stage-III-NSCLC-Following-Chemoradiation/74952 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-24/7-Tips-for-Meeting-The-Joint-Commissions-Sterile-Compounding-Requirements-in-2024/73809 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Pharmacists-Must-Be-Leaders-in-AI-Development/74779 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/GI-Disorders/Article/10-24/New-Guideline-for-H-pylori-Changes-Primary-Treatment-Recommendation/74940 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Oncology/Article/10-24/new-onset-diabetes-pancreatic-cancer-signs/74899 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Focusing-on-the-Final-Link-in-the-Cold-Chain/74780 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Hematology/Article/10-24/-FDA-Approves-Sarclisa-With-Bortezomib-Lenalidomide-and-Dexamethasone-for-Newly-Diagnosed-Multiple-Myeloma/74930 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/10-24/Nasal-Spray-Influenza-Vaccine-Approval/74933 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/-FDA-Approves-Rybrevant-for-NSCLC-With-EGFR-Exon-19-Deletions-or-L858R-Mutations/74929 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Monographs-and-Whitepapers/Article/02-26/Gohibic-trade-vilobelimab-A-Treatment-Option-For-Critically-Ill-COVID-19-Patients/74925 2026-02-17 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/10-24/AI-Medication-Management-Atlantic-Health/74768 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Pain/Article/10-24/Telehealth-May-Ease-Some-Stigma-Linked-to-Treatment-for-OUD/74901 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/GI-Disorders/Article/10-24/GLP-1s-responders-AI-picks-ozempic-obesity/74891 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Medication-Safety/Article/10-24/Fractal-Management-Boosts-Smart-Pump-Safety/74766 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Opinion/Article/10-24/Armageddon-The-Why-to-War-Games/74900 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Medication-Safety/Article/10-24/Xylazine-Wounds-Opioid-Adulteration-Massachusetts/74903 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Article/10-24/Atovaquone-Oral-Suspension-Recalled-Due-to-Bacterial-Contamination/74922 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/10-24/nutrition-drug-interaction-transplant-patients-liver-transplant/74893 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Inflammatory-Diseases/Article/10-24/FDA-Approves-Fasenra-for-EGPA/74908 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Meningococcal-Cases-Increasing-in-U-S/74906 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Remote-Patient-Monitoring-Faces-Adoption-Hurdles/74769 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Online-First/Nutrition/Article/10-24/apraglutide-short-bowel-syndrome-GLP-2-drug/74897 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/FDA-Approves-Keytruda-With-Chemo-for-Unresectable-Advanced-or-Metastatic-Malignant-Pleural-Mesothelioma/74895 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/Kisqali-With-an-AI-and-Kisqali-Femara-Co-Pack-Approved-for-Early-High-Risk-Breast-Cancer/74874 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Healthcare-Technology-Pharmacy-Customers/74867 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Oncology/Article/10-24/FDA-Approves-Tecentriq-Hybreza-for-Subcutaneous-Injection-for-All-Adult-Indications-of-IV-Tecentriq/74859 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-24/Juggling-State-Rules-And-Joint-Commission-A-Key-in-2025-Surveys/74742 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Nutrition/Article/10-24/Feeding-Challenges-in-the-ICU-Avoiding-Necrosis-and-Other-Risks/74741 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com//GI-Disorders/Article/10-24/guselkumab-tremfya-ulcerative-colitis-approval-FDA/74846 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Pharmacogenomics/Article/01-25/PGx-May-Take-Edge-Off-Pain-Management/74743 2025-01-16 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Article/10-24/A-Summary-of-Selected-2023-2024-FDA-MedWatch-Alerts/74748 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/11-24/Pharmacy-Organizations-Raise-Alarm-on-DSCSA/74767 2024-11-08 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/DoxyPrEP-Reduces-Bacterial-STIs/74746 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Infectious-Diseases/Article/10-24/FDA-Committee-Weighs-New-Oral-uUTI-Antibiotic/74830 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Covid-19/Infectious-Diseases/Article/10-24/IDSA-Updates-COVID-19-Treatment-Guidelines-to-Include-Pemgarda/74813 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Operations-and-Management/Article/10-24/Offsetting-High-Drug-Costs-Is-a-Moving-Target/74750 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Pharmacy-Groups-Urge-Action-After-Change-Healthcare-Attack/74773 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Pharmacy-Technology-Report/Article/10-24/Free-ASHP-Tool-Helps-Identify-Drug-Diversion-Gaps/74770 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Article/10-24/Pharmacy-Organizations-Raise-Alarms-on-DSCSA-Preparedness/74740 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Policy/Biosimilars/Article/10-24/FDA-Updates-Biosimilars-Action-Plan/74749 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/FDA-Approves-Authorizes-Updated-COVID-19-Vaccines/74747 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Failing-to-Meet-Global-Targets-Means-17-7-Million-More-AIDS-Related-Deaths/74745 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/Clinical/Infectious-Diseases/Article/10-24/Bictegravir-Lenacapavir-an-Effective-ART-Switch/74744 2024-10-29 monthly 0.6 https://www.pharmacypracticenews.com/FDA-News/Article/11-24/FDA-Grants-Accelerated-Approval-to-Tecelra-for-Unresectable-or-Metastatic-Synovial-Sarcoma/75521 2024-11-21 monthly 0.6 https://www.pharmacypracticenews.com/CME 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/BuyersGuide 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/Multimedia 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/MeetingSchedule 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/Classifieds 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/SRD 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/Digital-Issue 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/ConferenceCalendar 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/ConferenceNews 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/CorporateProfiles 2026-04-09 yearly 0.5 https://www.pharmacypracticenews.com/Webinar 2026-04-09 yearly 0.5